[go: up one dir, main page]

DE60002952D1 - Verfahren zur selektiven Abtrennung und Reinigung von Eicosapentaensäure und Decosohexaensäure und deren Estern - Google Patents

Verfahren zur selektiven Abtrennung und Reinigung von Eicosapentaensäure und Decosohexaensäure und deren Estern

Info

Publication number
DE60002952D1
DE60002952D1 DE60002952T DE60002952T DE60002952D1 DE 60002952 D1 DE60002952 D1 DE 60002952D1 DE 60002952 T DE60002952 T DE 60002952T DE 60002952 T DE60002952 T DE 60002952T DE 60002952 D1 DE60002952 D1 DE 60002952D1
Authority
DE
Germany
Prior art keywords
acid
esters
decosohexaenoic
purification
flowing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002952T
Other languages
English (en)
Other versions
DE60002952T2 (de
Inventor
Satoshi Kiyohara
Shiro Fujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Pharma Inc
Original Assignee
Nisshin Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc filed Critical Nisshin Pharma Inc
Application granted granted Critical
Publication of DE60002952D1 publication Critical patent/DE60002952D1/de
Publication of DE60002952T2 publication Critical patent/DE60002952T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DE60002952T 1999-06-28 2000-06-21 Verfahren zur selektiven Abtrennung und Reinigung von Eicosapentaensäure und Decosohexaensäure und deren Estern Expired - Fee Related DE60002952T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18140799 1999-06-28
JP18140799 1999-06-28

Publications (2)

Publication Number Publication Date
DE60002952D1 true DE60002952D1 (de) 2003-07-03
DE60002952T2 DE60002952T2 (de) 2004-03-11

Family

ID=16100230

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002952T Expired - Fee Related DE60002952T2 (de) 1999-06-28 2000-06-21 Verfahren zur selektiven Abtrennung und Reinigung von Eicosapentaensäure und Decosohexaensäure und deren Estern

Country Status (7)

Country Link
US (1) US6313330B1 (de)
EP (1) EP1065196B1 (de)
AT (1) ATE241584T1 (de)
CA (1) CA2311974A1 (de)
DE (1) DE60002952T2 (de)
DK (1) DK1065196T3 (de)
NO (1) NO321273B1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2251429T3 (pl) 2003-12-30 2017-08-31 Dsm Ip Assets B.V. Sposób odpowietrzania
ES2617577T3 (es) * 2005-07-08 2017-06-19 Dsm Ip Assets B.V. Ácidos grasos poliinsaturados para el tratamiento de la demencia y afecciones relacionadas con la pre-demencia
US20090023808A1 (en) * 2007-06-29 2009-01-22 Martek Biosciences Corporation Production and Purification of Esters of Polyunsaturated Fatty Acids
ES2862336T3 (es) 2008-09-02 2021-10-07 Amarin Pharmaceuticals Ie Ltd Composición farmacéutica que comprende ácido eicosapentaenoico y ácido nicotínico y métodos de uso de la misma
JP5503856B2 (ja) 2008-09-10 2014-05-28 キユーピー株式会社 高度不飽和脂肪酸誘導体の取得方法
JP5872453B2 (ja) 2009-04-17 2016-03-01 ナタク ファルマ エセ．エレ． フィタン酸含量が低く、ω−３脂肪酸に富む組成物
WO2010127099A2 (en) 2009-04-29 2010-11-04 Amarin Corporation Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NZ595852A (en) 2009-04-29 2014-07-25 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
SMT202100223T1 (it) 2009-06-15 2021-05-07 Amarin Pharmaceuticals Ie Ltd Composizioni e metodi per abbassare i trigliceridi senza aumentare i livelli di ldl-c in un soggetto in terapia concomitante con statine
RU2012116079A (ru) 2009-09-23 2013-10-27 АМАРИН КОРПОРЕЙШН ПиЭлСи Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина и способы ее применения
KR101761959B1 (ko) 2009-12-30 2017-07-26 바스프 파마 (칼라니쉬) 리미티드 다중 불포화 지방산을 정제하기 위한 시뮬레이션된 이동상 크로마토그래피 분리 방법
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2646013A4 (de) 2010-11-29 2014-03-26 Amarin Pharma Inc Zusammensetzung mit geringem aufstosseffekt und verfahren zur behandlung und/oder vorbeugung kardiovaskulärer erkrankungen bei einem patienten mit fischallergie/-überempfindlichkeit
GB201111594D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New improved process
GB201111595D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Improved process
GB201111589D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New modified process
GB201111601D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New process
GB201111591D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Further new process
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
NZ703267A (en) 2012-06-29 2017-01-27 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
GB201300354D0 (en) 2013-01-09 2013-02-20 Basf Pharma Callanish Ltd Multi-step separation process
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9428711B2 (en) 2013-05-07 2016-08-30 Groupe Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US8802880B1 (en) 2013-05-07 2014-08-12 Group Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CN103962091B (zh) * 2013-11-28 2017-01-25 大连工业大学 一种银离子改性氨基硅胶分离epa和dha的方法
EP2883860B1 (de) 2013-12-11 2016-08-24 Novasep Process Chromatografisches Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren
US10975031B2 (en) 2014-01-07 2021-04-13 Novasep Process Method for purifying aromatic amino acids
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
PL4056176T3 (pl) 2018-09-24 2024-08-26 Amarin Pharmaceuticals Ireland Limited Sposoby zmniejszania ryzyka zdarzeń krążeniowo-naczyniowych u osobnika
US11767491B2 (en) 2019-03-26 2023-09-26 Nisshin Pharma Inc. Eicosapentaenoic acid alkyl ester-containing composition and method for producing same
CN109912403A (zh) * 2019-04-18 2019-06-21 南京市第一医院 一种Omega-3制备大电导钙激活钾通道开放剂的方法
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347509A1 (de) * 1988-06-21 1989-12-27 Century Laboratories Inc. Verfahren zur Extraktion und Reinigung von polyungesättigten Fettsäuren aus Naturquellen
JPH028298A (ja) * 1988-06-17 1990-01-11 Agency Of Ind Science & Technol イカ内臓からドコサヘキサエン酸及びエイコサペンタエン酸を選択的に分離精製する方法
JPH07242895A (ja) * 1993-03-16 1995-09-19 Ikeda Shiyotsuken Kk 高純度エイコサペンタエン酸又はその低級アルコールエステルの分離精製法
JPH09151390A (ja) * 1995-11-30 1997-06-10 Bizen Kasei Kk 高度不飽和脂肪酸及びその誘導体の精製方法
JPH10310551A (ja) * 1997-05-12 1998-11-24 Nippon Wax Polymer Kaihatsu Kenkyusho:Kk エイコサペンタエン酸又はそのエステルの精製方法

Also Published As

Publication number Publication date
CA2311974A1 (en) 2000-12-28
DE60002952T2 (de) 2004-03-11
ATE241584T1 (de) 2003-06-15
US6313330B1 (en) 2001-11-06
NO321273B1 (no) 2006-04-10
NO20003335D0 (no) 2000-06-26
EP1065196A1 (de) 2001-01-03
NO20003335L (no) 2000-12-29
EP1065196B1 (de) 2003-05-28
DK1065196T3 (da) 2003-09-22

Similar Documents

Publication Publication Date Title
DE60002952D1 (de) Verfahren zur selektiven Abtrennung und Reinigung von Eicosapentaensäure und Decosohexaensäure und deren Estern
JP5951764B2 (ja) 魚油から高純度のｅｐａを生成するためのｓｍｂ方法
JP6153519B2 (ja) Ｓｍｂ方法
ES2459951T3 (es) Proceso de separación cromatográfico de lecho móvil simulado para la purificación de ácidos grasos poliinsaturados
JP5990580B2 (ja) 新規なｓｍｂ方法
ATE110103T1 (de) Verfahren zur extraktion von docosahexaensäureethylester aus fischölen und docosahexaen- und eicosapentaensäureethylester enthaltende pharmazeutische und/oder diät- zusammensetzungen.
JP5946833B2 (ja) ω３脂肪酸を濃縮する方法
JP5990267B2 (ja) 改善されたｓｍｂ方法
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
ATE224352T1 (de) Verfahren zum herstellen von fettsäureester
DE60106178D1 (de) Verfahren zur Isolierung von hochgereinigten ungesättigten Fettsäuren mittels Kristallisation
ATE406345T1 (de) Reinigung von aminosäuren durch chromatographische simulierte wanderbetttrennung
ES2905647T3 (es) Proceso para la producción de ácido graso altamente insaturado de una pureza alta con un rendimiento alto
DE59008608D1 (de) Verfahren zur sulfierung ungesättigter fettsäureglycerinester.
DE59304941D1 (de) Verfahren zum Abtrennen von Aminosäuren aus wässrigen Lösungen
DE69013092D1 (de) Verfahren zur Isolation von Hydroxyfettsäurederivaten aus Convolvulaceae-Pflanzen.
DE58904353D1 (de) Verfahren zur herstellung von methacrylsaeure durch oxidation von methacrolein.
DE69505347D1 (de) Verfahren zum Reinigen von alpha,beta-ungesättigten Estern
DE60130337D1 (de) Gereinigte polyoxypropylen-fettsäure isopropanolamid tenside, verfahren zu deren herstellung und diese enthaltende waschmittelzusammensetzung
ATE402695T1 (de) Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
DE59201466D1 (de) Verfahren zur herstellung von einfach ungesättigten fettsäuren oder deren derivaten.
JPS56115736A (en) Separation and purification of eicosapentaenoic acid and docosahexaenoic acid
DE59201724D1 (de) Verfahren zur Herstellung von höheren Alkoholen durch katalytische Hydrierung von Carbonsäurealkylestern.
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
FR2646669B1 (fr) Procede de separation enantiomeriquement selective des esters des acides halogeno-2 propioniques

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee